Organisation Description

Optos is an innovative retinal imaging company with a vision to be recognised as a leading provider of devices and solutions to ophthalmic professionals for improved patient care. Optos designs, develops, manufactures and markets retinal imaging devices that create optomap images. The optomap is the only image that provides an ultra-wide 82% view of the retina. A simple optomap scan is an important tool for the screening, early detection and diagnosis of eye problems such as retinal detachment, glaucoma, cataracts, retinal holes/retinal tears and age-related macular degeneration. It can also indicate evidence of non-eye diseases such as diabetes, hypertension and certain cancers.
The company features a very positive and unique culture which has resulted in a world-beating product, the addressing of the markets in a novel manner and service, reliability and performance to world class standards. Quality is approved to both ISO and FDA levels.
standards. Quality is approved to both ISO and FDA levels

Product/Research Description

Optos’ platform technology is the P200 series of Scanning Laser Ophthalmoscope devices – the P200, P200C and P200MA. Each device produces high resolution images (optomaps) of up to 200 degrees or approximately 82% of the retina in a single capture which takes a quarter of a second. The Optos devices are used by clinical optometrists as part of their comprehensive eye examinations and by ophthalmologists in the treatment and management of eye-related conditions.

Quality Standards

ISO13485: Medical Devices, Quality Management Systems
US Food & Drug Administration: 21 CFR Part 820 Quality System Resulation

Main Markets

Ophthalmic specialists, opticians and other medical specialists over a wide range of diagnostic applications..